We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current SNOA market cap is 2.84M. The company's latest EPS is USD -0.3300 and P/E is -0.55.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.94M | 3.01M | 3.43M | 2.73M | 3.14M |
| Operating Income | -1.84M | -1.15M | -1.24M | -1.21M | -844k |
| Net Income | -1.94M | -1.31M | -1.42M | -1.48M | -866k |
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 18.97M | 18.94M | 18.63M | 12.63M | 13.27M |
| Operating Income | -11.26M | -6.67M | -3.45M | -5.89M | -4.57M |
| Net Income | -11.8M | -2.95M | -3.95M | -5.09M | -5.15M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 13.93M | 16.23M | 15.89M | 13.64M | 14.62M |
| Total Liabilities | 8.37M | 8.25M | 8.65M | 7.96M | 7.93M |
| Total Equity | 5.56M | 7.98M | 7.24M | 5.68M | 6.69M |
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.45M | 14.56M | 14.99M | 18.85M | 16.23M |
| Total Liabilities | 3.96M | 5.86M | 9.62M | 10.15M | 8.25M |
| Total Equity | 10.49M | 8.71M | 5.36M | 8.7M | 7.98M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.71M | -6.15M | -215k | -1.45M | -2.55M |
| Investing | -176k | -258k | -17k | -19k | -20k |
| Financing | -883k | 2.49M | -135k | -264k | 1.05M |
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.72M | -4.54M | -3.38M | -4.25M | -6.15M |
| Investing | -131k | 3.59M | 388k | -99k | -258k |
| Financing | 5.49M | 1.03M | 3.31M | 7.4M | 2.49M |
| Market Cap | 2.84M |
| Price to Earnings Ratio | -0.55 |
| Price to Sales Ratio | 0.21 |
| Price to Cash Ratio | 0.74 |
| Price to Book Ratio | 0.35 |
| Dividend Yield | - |
| Shares Outstanding | 15.61M |
| Average Volume (1 week) | 1.29M |
| Average Volume (1 Month) | 5.94M |
| 52 Week Change | -86.30% |
| 52 Week High | 1.38 |
| 52 Week Low | 0.1159 |
| Spread (Intraday) | 0 (0.44%) |
| Company Name | Sonoma Pharmaceuticals Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.sonomapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
